Amadeusz Juskowiak

Epitope epto sets three for one stock split

Epitope Inc said its board of directors has authorized a threeforone common stock split for which shareholder approval is expected in the next two weeks

The company announced a twoforone split last week but said the board reconvened and agreed to change it to a threeforone split

Epitope is involved in the production of monoclonal antibodies for diagnostic and therapeutic use in AIDS and other immunological diseases